🎗️ United States Pancreatic Cancer Precision Medicine Market The U.S. pancreatic cancer precision medicine market is set to rise from US$ 183.61M in 2024 to US$ 694.48M by 2033, showing strong growth with a 15.93% CAGR. Advances in personalized oncology, improved diagnostics, and targeted therapies are driving this rapid expansion. 🔗 https://www.renub.com/united-states-pancreatic-cancer-precision-medicine-market-p.php #PrecisionMedicine #Oncology #PancreaticCancer #USHealthcare #MedicalInnovation #CancerResearch #MarketForecast